Hanmi Pharm Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Hanmi Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hanmi Pharm Co Ltd (128940) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩42.02 Billion ≈ $28.48 Million USD) by net assets (₩1.35 Trillion ≈ $911.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hanmi Pharm Co Ltd (2010–2024)

Cash flow conversion efficiency of Hanmi Pharm Co Ltd from 2010 to 2024. This chart illustrates how Hanmi Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Hanmi Pharm Co Ltd for real-time trading data and today's change.

Hanmi Pharm Co Ltd Cash Flow Conversion Ratio Explained

Hanmi Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hanmi Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hanmi Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see 128940 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Post Holdings Inc NYSE:POST	0.069x
SL Green Realty Corp NYSE:SLG	-0.020x
Ottobock SE & Co. KGaA XETRA:OBCK	0.133x
Organon & Co NYSE:OGN	0.106x
Mueller Water Products NYSE:MWA	-0.012x
RUBIS F:BYN	N/A
The a2 Milk Company Ltd AU:A2M	0.035x
Krones AG XETRA:KRN	0.010x

Annual Cash Flow Conversion Efficiency for Hanmi Pharm Co Ltd (2010–2024)

The table below shows the annual cash flow conversion efficiency of Hanmi Pharm Co Ltd from 2010 to 2024. Review 128940 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩1.24 Trillion ≈ $840.84 Million	₩193.49 Billion ≈ $131.12 Million	0.156x	-20.77%
2023-12-31	₩1.10 Trillion ≈ $745.60 Million	₩216.54 Billion ≈ $146.74 Million	0.197x	+22.41%
2022-12-31	₩1.01 Trillion ≈ $683.94 Million	₩162.27 Billion ≈ $109.97 Million	0.161x	-26.09%
2021-12-31	₩928.26 Billion ≈ $629.07 Million	₩201.92 Billion ≈ $136.84 Million	0.218x	+19.42%
2020-12-31	₩831.89 Billion ≈ $563.76 Million	₩151.53 Billion ≈ $102.69 Million	0.182x	+1103.39%
2019-12-31	₩822.26 Billion ≈ $557.23 Million	₩12.45 Billion ≈ $8.43 Million	0.015x	-54.02%
2018-12-31	₩789.26 Billion ≈ $534.87 Million	₩25.98 Billion ≈ $17.61 Million	0.033x	+141.47%
2017-12-31	₩792.42 Billion ≈ $537.01 Million	₩-62.91 Billion ≈ $-42.63 Million	-0.079x	-114.12%
2016-12-31	₩734.52 Billion ≈ $497.77 Million	₩412.97 Billion ≈ $279.86 Million	0.562x	+311.70%
2015-12-31	₩744.81 Billion ≈ $504.75 Million	₩101.71 Billion ≈ $68.93 Million	0.137x	+345.18%
2014-12-31	₩589.25 Billion ≈ $399.32 Million	₩-32.82 Billion ≈ $-22.24 Million	-0.056x	-129.98%
2013-12-31	₩462.92 Billion ≈ $313.71 Million	₩85.99 Billion ≈ $58.28 Million	0.186x	+20.19%
2012-12-31	₩409.34 Billion ≈ $277.41 Million	₩63.27 Billion ≈ $42.88 Million	0.155x	-4.64%
2011-12-31	₩378.22 Billion ≈ $256.32 Million	₩61.30 Billion ≈ $41.54 Million	0.162x	+178.39%
2010-12-31	₩325.38 Billion ≈ $220.50 Million	₩18.94 Billion ≈ $12.84 Million	0.058x	--

About Hanmi Pharm Co Ltd

KO:128940 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$3.57 Billion

₩5.26 Trillion KRW

Market Cap Rank

#4275 Global

#90 in Korea

Share Price

₩415000.00

Change (1 day)

+6.82%

52-Week Range

₩311500.00 - ₩626000.00

All Time High

₩666173.23